01 1MEDISCA Inc.
02 1Medisca Inc.
03 1SMS Lifesciences India Limited
04 1SMS Pharmaceuticals Limited
05 1Solara Active Pharma Sciences Limited
06 1Union Quimico Farmaceutica SA
07 1Uquifa Spain
01 6Ranitidine Hydrochloride
02 1Ranitidine Hydrochloride Form II
01 3India
02 2Spain
03 2U.S.A
NDC Package Code : 38779-3186
Start Marketing Date : 2019-05-22
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0536
Start Marketing Date : 2011-05-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72375-0002
Start Marketing Date : 2018-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67835-0004
Start Marketing Date : 2009-05-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72643-012
Start Marketing Date : 1983-06-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49711-0112
Start Marketing Date : 2009-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49711-0107
Start Marketing Date : 2009-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
40
PharmaCompass offers a list of Ranitidine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ranitidine Hydrochloride manufacturer or Ranitidine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ranitidine Hydrochloride manufacturer or Ranitidine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ranitidine Hydrochloride API Price utilized in the formulation of products. Ranitidine Hydrochloride API Price is not always fixed or binding as the Ranitidine Hydrochloride Price is obtained through a variety of data sources. The Ranitidine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ergan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ergan, including repackagers and relabelers. The FDA regulates Ergan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ergan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ergan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ergan supplier is an individual or a company that provides Ergan active pharmaceutical ingredient (API) or Ergan finished formulations upon request. The Ergan suppliers may include Ergan API manufacturers, exporters, distributors and traders.
click here to find a list of Ergan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ergan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ergan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ergan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ergan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ergan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ergan suppliers with NDC on PharmaCompass.
We have 5 companies offering Ergan
Get in contact with the supplier of your choice:
